Trichomonas vaginalis infection in human immunodeficiency virus-seropositive Nigerian women: The public health significance

Online Journal of Health and Allied Sciences

Volumn 6, Issue 2, 2007, Pages

  Uneke, Chigozie Jesse ^a   Alo, Moses Nnaemeka ^a   Ogbu, Ogbonnaya ^a   Ugwuoru, Duhu Clifford ^a  

^a EBONYI STATE UNIVERSITY   (Nigeria)

Author keywords

HIV; Prevalence; Trichomonas vaginalis; Women

Indexed keywords

EID: 37349066753     PISSN: None     EISSN: 09725997     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rein MF. Trichomonas vaginalis. In Principles and Practices of Infectious Diseases, eds Mandell GL, Bennet JE & Dolin R (eds). Churchill Livingston. New York: 1995. pp. 2493-2497.
2. Petrin D, Dalgaty K, Bhatt R,Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11:300-317.
3. Danesh IS, Stephen JM, Gorbach J. Neonatal Trichomonas vaginalis infection. J Emerg Med. 1995;13:51-54.
4. Sobel JD. Vaginitis. NEJM. 1996;337:1896-1903.
5. Coth MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis. 1997;24:353-360.
6. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstetr Gynecol. 1990;163:1016-1021.
7. Wolner-Hanssen P, Krieger J, Stevens CE. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261:571-576.
8. Laga M, Manoka A, Kivuvu M et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95-102.
9. Ghys PD, Diallo MO, Ettiegne-Traore V et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis. 1995;172:1371-1374.
10. ter Muelen J, Mgaya HN, Chang-Claude J et al. Risk factors for HIV infection in gynaecological inpatients in Dar Es Salaam, Tanzania, 1988-1990. East Afr Med J. 1992;69:688-692.
11. World Health Organization (WHO). AIDS epidemic update. UNAIDS/WHO; Geneva. 2004.
12. Federal Ministry of Health Nigeria (FMHN). National HIV/AIDS and Reproductive Health Survey. Abuja. 2003.
13. UNAIDS. 2004 Report on the global AIDS epidemic. UNAIDS; Geneva. 2004.
14. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis.1992;19:1-77.
15. Federal Ministry of Health Nigeria (FMHN). Technical report on 2003 National HIV/Syphilis Sentinel Survey among pregnant women attending antenatal clinics in Nigeria. FMHN; Abuja. 2004.
16. Madico G, Quinn TC, Rompalo A et al. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol. 1998;36:3205-3210.
17. Schwebke JR, Morgan SC, Pinson GB. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol. 1997;35:1618-1619.
18. Sutton MY, Sternberg M, Nsuami M et al. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstetr Gynecol. 1999;181:656-562.
19. Bersoff-Matcha SJ, Horgan MM, Fraser VJ, Mundy LM, Stoner BP. Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. Journal of Infectious Diseases, 1998;178:1174-1177.
20. Cu-Uvin S, Hogan JW, Warren D et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis. 1999;29:1145-1150.
21. Sorvillo F, Kovacs A, Kerndt P et al. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg. 1998;58:495-500.
22. Niccolai LM, Kopicko JJ, Kassie A et al. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis. 2000;27:284-288.
23. Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immunol. 2005;73:4155-4160.
24. Wiese W, Patel SR, Patel SC et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med. 2000;108:301-308.
25. Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980;141:137-143.
26. Krieger JN, Tam MR, Stevens CE et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988;259:1223-1227.
27. Rouet F, Ekouevi DK, Inwoley A et al. Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women. J Clin Microbiol. 2004;42:4147-4153.